The tyrosine kinase encoded by the BCR/ABL fusion gene can continuously activate downstream signaling pathways (such as RAS, PI3K/AKT) (45), leading to abnormal proliferation of leukemia cells and thus a significant increase in peripheral blood white blood cell counts. This evidence concerns the gene AKT1 and leukemia.